Execution of License Agreement on Flutiform, an Anti-asthmatic Treatment, in Japan
April 22, 2008
Execution of License Agreement on Flutiform™ , an Anti-asthmatic Treatment, in Japan Kyorin Pharmaceutical Co., Ltd. (Tokyo, President: Ikuo Ogihara), a subsidiary of Kyorin Co., Ltd., announces that it has entered into a License Agreement with SkyePharma PLC (United Kingdom, CEO: Mr. Frank Condella) as of April 22, 2008 on Flutiform™ , an anti-asthmatic treatment currently under development for Europe and the USA.
Please see the PDF file below for details.
